Talk:ABCC2

From Libre Pathology
Revision as of 01:16, 19 May 2026 by Michael (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Abstract

Castillo VF, Yacoub JM, Cornacchia K, Patel S, Mimosa M, Zakhary A, van der Kwast T, Trpkov K, Saleeb R, 2026, "Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition", Canadian Kidney Cancer Forum.

Retrieved from "https://librepathology.org/w/index.php?title=Talk:ABCC2&oldid=53788"